Laboratory of Neuropharmacology


Group Leader

Rafael Maldonado López

The Laboratory of Neuropharmacology (NeuroPhar) is a UPF research group that is associated with the IMIM. NeuroPhar studies the neurobiological substrate of drug addiction, pain, cognitive deficits, affective and eating disorders. The main interest of this research group is the development of research lines aimed at the identification of new therapeutic targets in the central nervous system.

The Laboratory of Neuropharmacology is interested in the neurochemical and neuroanatomical bases of addiction induced by opioids, cannabinoids, nicotine and psychostimulants.




Josep Eladi Baños Díez (Researcher)

Andrés Ozaita Mintegui (Researcher)


more info

Main Publications with IMIM

• Doly S, Quentin E, Eddine R, Tolu S, Fernández S, Bertran-González J, Valjent E, Belmer A, Viñals X, Callebert J, Faure P, Meye F, Herve D, Robledo P, Mameli M, Launay J-M, Maldonado R, Maroteaux L. Serotonin 2B receptors in mesoaccumbens dopamine pathway regulate cocaine responses. J Neurosci 2017; 37(43): 10372-10388. IF 5.988. Q1.



C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00